NeuroSense Therapeutics Ltd.

General ticker "NRSN" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $27.5M (TTM average)

NeuroSense Therapeutics Ltd. follows the US Stock Market performance with the rate: 9.0%.

Estimated limits based on current volatility of 4.9%: low 1.12$, high 1.23$

Factors to consider:

  • Earnings expected soon, date: 2025-12-17 bmo
  • Total employees count: 11 as of 2021
  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [0.78$, 2.14$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.74$, 2.03$]

Financial Metrics affecting the NRSN estimates:

  • Positive: with PPE of -3.6 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -43.39 <= 0.33
  • Positive: Investing cash flow per share per price, % of 0 > -0.66
  • Positive: Interest expense per share per price, % of 1.33 <= 3.41
  • Positive: 41.86 < Shareholder equity ratio, % of 56.46 <= 63.39
  • Negative: negative Industry operating cash flow (median)
  • Negative: negative Net income
  • Negative: -0.15 < Industry inventory ratio change (median), % of 0

Similar symbols

Short-term NRSN quotes

Long-term NRSN plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $13.55MM $12.05MM $9.90MM
Operating Income $-13.55MM $-12.05MM $-9.90MM
Non-Operating Income $1.21MM $0.77MM $-0.31MM
Interest Expense $0.01MM $0.55MM $0.31MM
R&D Expense $6.42MM $7.27MM $5.70MM
Income(Loss) $-12.34MM $-11.28MM $-10.21MM
Taxes $-1.14MM $0.00MM $0.00MM
Profit(Loss)* $-12.34MM $-11.28MM $-10.21MM
Stockholders Equity $5.62MM $-1.87MM $2.58MM
Inventory $3.68MM $0.00MM $0.00MM
Assets $7.71MM $3.18MM $4.58MM
Operating Cash Flow $-7.59MM $-8.35MM $-10.13MM
Capital expenditure $0.07MM $0.03MM $0.00MM
Investing Cash Flow $-3.54MM $3.47MM $0.00MM
Financing Cash Flow $3.69MM $3.98MM $10.91MM
Earnings Per Share** $-1.07 $-0.83 $-0.55

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.